| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/07/2004 | WO2004084816A2 IMPROVED CD4-IgG2 FORMULATIONS |
| 10/07/2004 | WO2004084812A2 Tamandarin analogs and fragments thereof and methods of making and using |
| 10/07/2004 | WO2004084805A2 Acetylated tat polypeptides and methods of use thereof |
| 10/07/2004 | WO2004084798A2 Antigen-presenting complex-binding compositions and uses thereof |
| 10/07/2004 | WO2004074432A9 Antibody vaccine conjugates and uses therefor |
| 10/07/2004 | WO2004069873A3 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 10/07/2004 | WO2004067568A3 Human il-1 beta antagonists |
| 10/07/2004 | WO2004040262A8 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 10/07/2004 | WO2004029206A3 Targeted cd1d molecules |
| 10/07/2004 | WO2004026427A3 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| 10/07/2004 | WO2004021999A3 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 10/07/2004 | WO2003091415A3 Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color |
| 10/07/2004 | WO2003089575A3 Antibodies that specifically bind to tl5 |
| 10/07/2004 | WO2003083059A3 Mcp-1 mutant proteins, antibodies, compositions, methods and uses |
| 10/07/2004 | WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |
| 10/07/2004 | WO2003070768A3 Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
| 10/07/2004 | WO2002092000A3 Hbm variants that modulate bone mass and lipid levels |
| 10/07/2004 | WO2002088317A3 Fusion molecules and methods for treatment of immune diseases |
| 10/07/2004 | US20040199945 Preparing heavy chain binding protein microarray in plant cells via genetic transformation and gene expression; tissue engineering; diagnostic antibody microarrays |
| 10/07/2004 | US20040198966 1-{3'-O-benzoyl-4'-O-[(4,4'-dimethoxytriphenyl)methyl]- beta -D-ribopyranosy}thymine preparation using solid phase synthesis |
| 10/07/2004 | US20040198962 Immunotherapy; antitumor agents |
| 10/07/2004 | US20040198961 Fce fusion proteins for treatment of allergy and asthma |
| 10/07/2004 | US20040198960 Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae |
| 10/07/2004 | US20040198959 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 10/07/2004 | US20040198958 Isolating maltose or chitin binding protein from mixture via perfusion of mixture through immobilized ligand carrier conjugate matrix; protein isolation |
| 10/07/2004 | US20040198957 Method for removing endotoxins from protein solutions |
| 10/07/2004 | US20040198953 Generating monoclonal and polyclonal antibodies for use in bioassays specific for the detection rapamycin; detection of immunosuppresant polypeptides or amino acid sequences |
| 10/07/2004 | US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides |
| 10/07/2004 | US20040198661 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 10/07/2004 | US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040198635 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 10/07/2004 | US20040197910 Gene regulation in transgenic animals using a transposon-based vector |
| 10/07/2004 | US20040197904 Method for separating cells using immunorosettes |
| 10/07/2004 | US20040197890 Comprises heat resistant enzymatic polypeptide for bioremediation of plant biomass and pollution control; reuse |
| 10/07/2004 | US20040197871 for diagnosing and treating inflammatory bowel disease using purified polypeptide; genetic engineering |
| 10/07/2004 | US20040197866 library can be used to select and screen for new monoclonal antibodies, and to optimize; genetic engineering |
| 10/07/2004 | US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering |
| 10/07/2004 | US20040197861 receptor-based gene expression modulation system for drug screening; genetic engineering |
| 10/07/2004 | US20040197842 for monitoring patients in vitro over time which can reveal changes in risk for hypercoagulation or other coagulopathies and/or effectiveness of anticoagulant therapy |
| 10/07/2004 | US20040197838 for creating this postranslational modification in vivo; genetic engineering; solid phase synthesis; kits |
| 10/07/2004 | US20040197831 Determining the level in blood or serum and comparing to that of a healthy subject, where a lower concentration indicates the risk Alzheimer's Disease; enzyme-linked immunosorbent assay |
| 10/07/2004 | US20040197830 Diagnostic assay for human matrix Gla-protein and its use as a biomarker |
| 10/07/2004 | US20040197823 Compositions and methods for aa4rp assay |
| 10/07/2004 | US20040197809 Immunoglobulin fusion for prevention or treatment of viral infection; immunotherapy |
| 10/07/2004 | US20040197798 Using alteration in phosphorylation to detect, diagnose, prevent and prognose cell proliferative disorders |
| 10/07/2004 | US20040197786 Method of examining steroid resnponsiveness |
| 10/07/2004 | US20040197783 Comprises nucleotide sequences coding modulator for treatment and prevention of tumor disorders; antisense/antitumor agents; immunotherapy |
| 10/07/2004 | US20040197782 Nucleic acid sequences mixture for detection of cutaneous t-cell lymphomas (CTCL); antitumor agents |
| 10/07/2004 | US20040197770 Induction of apoptosis by HIV-1 infected monocytic cells |
| 10/07/2004 | US20040197345 Prostate derived Ets factor |
| 10/07/2004 | US20040197339 Deer blood serum containing Borella and antibody thereof |
| 10/07/2004 | US20040197338 Sequening peptide fragments which bind to proteins; prevention reproduction of respiratory syncytial virus |
| 10/07/2004 | US20040197337 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 10/07/2004 | US20040197336 Antitumor, anticarcinogenic agents |
| 10/07/2004 | US20040197334 Extracellular glycoprotein with antigen binding zones; anticancer agents |
| 10/07/2004 | US20040197333 Use of TGF-beta antagonists to inhibit tumor cell formation or progression |
| 10/07/2004 | US20040197332 antiproliferative agents; antitumor and anticancer agents; monoclonal antibodies produced by hybridomas cell ling |
| 10/07/2004 | US20040197330 Binding to lecithin receptor; viricides |
| 10/07/2004 | US20040197329 Remedies or preventives for rheumatoid arthritis |
| 10/07/2004 | US20040197328 Screening; separation using cancer cytotoxicity; diagnosis; anticancer, antitumor agents; administering monoclonal antibodies |
| 10/07/2004 | US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents |
| 10/07/2004 | US20040197326 Using immunoglobulin antagonist; antiallergens; antihistamines |
| 10/07/2004 | US20040197325 Antibodies against GPR64 and uses thereof |
| 10/07/2004 | US20040197312 Anticancer agents; synergistic mixture of vaccine and antibodies , interferon or drug |
| 10/07/2004 | DE102004013282A1 ELISA-Kits zum Nachweis von Kollagenase 3 als Proenzym und in aktivierter Form in Körperflüssigkeiten und Zellkulturüberständen ELISA kits for the detection of collagenase 3 as a proenzyme and in activated form in body fluids and cell culture supernatants |
| 10/07/2004 | CA2520711A1 Diagnosis of advanced cancer |
| 10/07/2004 | CA2520254A1 Treatment of viral infections |
| 10/07/2004 | CA2520138A1 Improved fc fusion proteins |
| 10/07/2004 | CA2519982A1 Antigen-presenting complex-binding compositions and uses thereof |
| 10/07/2004 | CA2519528A1 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 10/07/2004 | CA2519313A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 10/07/2004 | CA2519234A1 Tamandarin analogs and fragments thereof and methods of making and using |
| 10/07/2004 | CA2519227A1 Nogo receptor binding protein |
| 10/07/2004 | CA2519089A1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 10/07/2004 | CA2519057A1 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 10/07/2004 | CA2518792A1 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/06/2004 | EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases |
| 10/06/2004 | EP1464704A2 Mouse adhesion molecule occludin |
| 10/06/2004 | EP1464703A2 Canine adhesion molecule occludin |
| 10/06/2004 | EP1464702A1 Method of stabilizing protein |
| 10/06/2004 | EP1463949A2 Diagnostics and vaccines for mycobacterium paratuberculosis infections |
| 10/06/2004 | EP1463948A2 Uses of an endothelial cell receptor |
| 10/06/2004 | EP1463942A2 Methods for purifying protein |
| 10/06/2004 | EP1463928A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 10/06/2004 | EP1463817A2 Histamine receptor h3 polynucleotides |
| 10/06/2004 | EP1463806A2 Novel cyclooxygenase variants and methods of use |
| 10/06/2004 | EP1463761A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| 10/06/2004 | EP1463760A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463754A2 Cystine-knot fold protein |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/06/2004 | EP1463529A2 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 10/06/2004 | EP1463527A2 The use of gammaglobulin for the treatment of immune-mediated diseases |
| 10/06/2004 | EP1463524A2 METHODS OF THERAPY FOR NON−HODGKIN S LYMPHOMA |
| 10/06/2004 | EP1463522A1 Human antipneumococcal antibodies from non-human animals |
| 10/06/2004 | EP1463479A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 10/06/2004 | EP1171470B1 Antibodies to placental protein 13 |
| 10/06/2004 | EP1073464B1 Monoclonal antibodies with reduced immunogenicity |